Home

Results 11 - 20 of 656,375 for medical products. Search took 1.993 seconds.  
Sort by date/Sort by relevance
Tackling illicit trade in medical products: Better international cooperation for better health 24 Tackling illicit trade in medical products Potential next steps in the fight against illicit trade4 Tackling illicit trade in medical products requires a global and multifaceted response, and the WTO offers a strong framework to anchor the trade-related features of that response. (...) Coordinate efforts with the public and private sectors to improve the quality and analysis of data on trade in medical products. Raise awareness of the value of WTO rules and trade policy activities in the fight against illicit trade in medical products. (...) This publication explores WTO tools and activities that can help WTO members develop and strengthen their trade policy responses to combat illicit trade in medical products. Tackling illicit trade in medical products Better international cooperation for better health
Language:English
Score: 960989.9 - https://www.wto.org/english/re...ling-illicit-trade_chap4_e.pdf
Data Source: un
Tackling illicit trade in medical products: Better international cooperation for better health 6 Tackling illicit trade in medical products Problem of illicit trade in medical products1 KEY POINT Measuring illicit trade and its impact is challenging; illicit trade in the medical product sector adversely impacts poverty and health. (...) In this context, the perils associated with illicit trade have faced fresh scrutiny (see Box 1). 7Problem of illicit trade in medical products Illicit trade in medical products poses a persistent and evolving threat Illicit trade in medical products threatens human welfare, endangering the health and safety of people and denying them and communities of critical resources. (...) Illicit trade in numbersBOX 2 9Problem of illicit trade in medical products Impact for people of illicit trade in medical products The effort to assess the impact of illicit trade in medical products on the lives and livelihoods of people has been more qualitative in nature.
Language:English
Score: 960811.1 - https://www.wto.org/english/re...ling-illicit-trade_chap1_e.pdf
Data Source: un
Select language Select language English South-East Asia India Home Health topics Our work News Emergencies  About us Home / News / Detail / 2nd World Conference on Access to Medical Products: Achieving the SDGs 2030 2nd World Conference on Access to Medical Products: Achieving the SDGs 2030 10 October 2018 Highlights 9-11 October 2018, New Delhi To enable a holistic view on access to medical products, the Ministry of Health & Family Welfare (MoHFW), Government of India with the support of World Health Organization is organizing the ‘2nd World Conference on Access to Medical Products - Achieving the SDGs 2030’ at New Delhi from 9 -11 October 2018. (...) UHC includes appropriate access to affordable and quality-assured medical products supporting countries in achieving the targets of the health SDGs. India’s contribution towards access to medical products worldwide is well recognized. The main objective of the 2nd World Conference 2018 is to take forward the recommendations from the 1st World Conference 2017 and build on the work done for access to medical products in the context of SDGs, including trade agreements.
Language:English
Score: 960669.4 - https://www.who.int/india/news...oducts-achieving-the-sdgs-2030
Data Source: un
How the system works Some Member States submit reports of suspected SF medical products and others submit reports of validated SF medical products. (...) In November 2017, the WHO Director General launched two documents on the subject of substandard and falsified medical products. Press Release WHO Director General Speech at the Report Launch     Health systems Substandard and falsified medical products 28 November 2017 News release 1 in 10 medical products in developing countries is substandard or falsified Advice on reporting a suspected SF medical product If you suspect that you have an SF medical product or have suffered an adverse reaction which you believe was caused by a medical product you should consult a pharmacist or medical doctor and report the case to your National Medicines Regulatory Authority. (...) In emergencies please contact:  [email protected] WHO Medical Product Alerts When a report of an SF medical product is received, WHO will seek to validate the report.
Language:English
Score: 959382 - https://www.who.int/who-global...eillance-and-monitoring-system
Data Source: un
Those subheadings could cover products that are for non-medical use. 2 2 PRODUCT SCOPE Medical products, in general, are widely spread in different Chapters of the Harmonized System (HS) classification. (...) Table 1: Top 10 importers of medical goods, 2019 Country Total imports Share of world medical imports (%) Share of total medical imports (%) Value ($ billion) Share of imports of all products (%) Medical equipment Medical supplies Medicines Personal protective products World 1,011.3 6 100 14 17 56 13 1. (...) Italy 37.1 8 4 9 15 66 9 10 Switzerland 36.9 13 4 6 9 80 5 Source: WTO Secretariat. Medical equipment 14% Medical supplies 17% Medicines 56% Personal protective products 13% 2019 Total Imports of Medical Products: $1.01 Trillion 4 Personal protective products represent 13% of medical imports The import value of personal protective products (hand soap and sanitizer, face masks, and protective spectacles) in 2019 was $135 billion.
Language:English
Score: 959158.6 - https://www.wto.org/english/ne..._e/news20_e/rese_03apr20_e.pdf
Data Source: un
Please refer to   WHO medical product alert n°3/2020  for general information on falsified medical products in relation to the management  of COVID-19. WHO requests increased vigilance within the supply chains of countries likely to be affected by these falsified products. Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies and any other suppliers of medical products. All medical products must be obtained from licensed, authentic and reliable sources.
Language:English
Score: 959056.25 - https://www.who.int/news/item/...-medical-product-alert-n4-2020
Data Source: un
Circulation of these falsified medical products is confirmed in the WHO Region of the Eastern Mediterranean. (...) Laboratory analysis of the product GLUCANTIME is pending This medical product alert N°7/2019 will subsequently be updated and posted on the WHO website once results are known. (...) All medical products must be obtained from authentic and reliable sources.
Language:English
Score: 958706.7 - https://www.who.int/news/item/...ert-n-7-2019-(english-version)
Data Source: un
Such products are considered as PPE rather than medical devices. (...) The product(s) shall conform to the relevant International Organisation for Standardisation (ISO) standards for suppliers/manufacturers of medical devices and risk management. c. (...) Copy in English. For products classified as medical devices, valid ISO 13485 certificate.
Language:English
Score: 957379.9 - https://www.unicef.org/supply/...l-protective-equipment-PPE.pdf
Data Source: un
2nd World Conference on Access to Medical Products: Achieving the SDGs 2030 Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific Countries Countries in the WHO South-East Asia Region: Bangladesh Bhutan Democratic People’s Republic of Korea India Indonesia Maldives Myanmar Nepal Sri Lanka Thailand Timor-Leste When autocomplete results are available use up and down arrows to review and enter to select. Select language Select language English South-East Asia India Home Health topics Our work News Emergencies  About us Home / News / Detail / 2nd World Conference on Access to Medical Products - Achieving the SDGs 2030 2nd World Conference on Access to Medical Products - Achieving the SDGs 2030 10 October 2018 Highlights Day 2 update - 10 October 2018 The main sessions covered on Day 2 were: ’Strengthening Regulatory Networks for Facilitating Access to quality, safe and affordable Medical Products; Global Models for High-end Manufacturing of Medical Products; Standard setting and quality benchmarks for medical devices and Diagnostics in National and Global Markets; Medical Diagnostics in National and Global Markets; Promoting Health and Wellness through Traditional Medicine; Developing Efficiencies in Clinical Trials in Global, Regional and National Settings; and Access and Affordability of Medical Products with focus on Orphan and Rare drugs. Speaking at a session on `Global Models for High-end Manufacturing of Medical products’, Dr Renu Swarup, Senior Adviser, Department of Biotechnology (DBT) and Managing Director, Biotechnology Industry Research Assistance Council (BIRAC) stated that the start-up culture has gained a momentum in the country and there is a tremendous change in the mindset of researchers to move towards new medical developments.
Language:English
Score: 957260.3 - https://www.who.int/india/news...ucts---achieving-the-sdgs-2030
Data Source: un
Not only is this a waste of money for individuals and health systems that purchase these products, but substandard or falsified medical products can cause serious illness or even death. (...) WHO has received reports of substandard or falsified medical products ranging from cancer treatment to contraception. (...) These are especially popular in high-income countries, but more research is needed to determine the proportion and impact of sales of substandard or falsified medical products. Globalization is making it harder to regulate medical products.
Language:English
Score: 956206 - https://www.who.int/news/item/...es-is-substandard-or-falsified
Data Source: un